Exelixis, Inc.
EXEL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000939767
In the last 90 days, Exelixis, Inc. insiders filed 0 open-market purchases and 1 sale; 760 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.
Holders of 5% or more of EXEL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Exelixis, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 10.20%28.5M shares | – | Apr 28, 20251 filing | Apr 28, 2025 | SEC |
| Farallon Capital Partners, L.P. | 13D/A | 5.90%15.7M shares | −0.90 ppfrom 6.80% | Mar 5, 20253 filings | Jan 5, 2026 | SEC |
| Farallon Capital Management, L.L.C. | 13D/A | 5.60%14.0M shares | – | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.09%13.2M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
19 Schedule 13D and 13G filings on Exelixis, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20268:21 AM ET | Farallon Capital Management, L.L.C.and 28 others | 13D/A | 5.60%14.0M shares | – | Aug 14, 2026 | SEC |
| Aug 12, 20267:17 AM ET | AQR Capital Management LLCand 1 other | 13G/A | 4.39%11.0M shares | −0.70 ppfrom 5.09%Below 5% | Jun 30, 2026 | SEC |
| Apr 29, 20266:49 PM ET | Vanguard Capital Management LLC | 13G | 5.09%13.2M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20266:23 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 13, 202611:37 AM ET | AQR Capital Management LLCand 1 other | 13G | 5.09%13.7M shares | New | Dec 31, 2025 | SEC |
| Jan 5, 20266:05 PM ET | Farallon Capital Partners, L.P.and 30 others | 13D/A | 5.90%15.7M shares | −0.90 ppfrom 6.80% | Jan 1, 2026 | SEC |
| May 20, 20255:59 PM ET | Farallon Capital Partners, L.P.and 29 others | 13D/A | 6.80%18.6M shares | −1.60 ppfrom 8.40% | May 16, 2025 | SEC |
| Apr 28, 202510:24 AM ET | BlackRock, Inc. | 13G/A | 10.20%28.5M shares | – | Mar 31, 2025 | SEC |
| Mar 5, 20255:01 PM ET | Farallon Capital Partners, L.P.and 29 others | 13D/A | 8.40%23.4M shares | – | Mar 5, 2025 | SEC |
| Feb 14, 2022 | Price T Rowe Associates Inc | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jan 27, 20222:15 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20226:40 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Price T Rowe Associates Inc | 13GOld format | – | New | – | SEC |
| Feb 11, 2021 | Renaissance Technologies LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20217:14 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Exelixis, Inc. shares.
No Form 144 notices for Exelixis, Inc. are on file.